Lockdown Measures Negatively Impacted Cancer Care
| Autor: | Ludovica De Vincentiis, Ranjeet Singh Mahla, Filippo Crivelli, Luca Saragoni, Paolo Giorgi Rossi, Carmine Pinto, Enrico Orvieto, Mattia Barbareschi, Sarita Kumari, Ezio Venturino, Gerardo Ferrara, Lucia Mangone, Elda Feyles, Roberto Grilli |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Delayed Diagnosis Corrective procedures SARS-CoV-2 business.industry COVID-19 Histopathology Cancer General Medicine medicine.disease Coronavirus Italy Neoplasms Internal medicine Communicable Disease Control Diagnosis Humans Medicine Original Article business Pandemics AcademicSubjects/MED00690 |
| Zdroj: | American Journal of Clinical Pathology |
| ISSN: | 1943-7722 0002-9173 |
| DOI: | 10.1093/ajcp/aqaa243 |
| Popis: | Objectives We performed data collection concerning the coronavirus disease 2019 (COVID-19) pandemic-related delay in the diagnosis of cancers to individuate proper corrective procedures. Methods A comparison was made among the number of first pathologic diagnoses of malignancy made from weeks 11 to 20 of 2018, 2019, and 2020 at seven anatomic pathology units serving secondary care hospitals in northern-central Italy. Results Cancer diagnoses fell in 2020 by 44.9% compared with the average number recorded in 2018 and 2019. Melanoma and nonmelanoma skin cancer represented 56.7% of all missing diagnoses. The diagnostic decrease in colorectal (–46.6%), prostate (–45%), and bladder (–43.6%) cancer was the most relevant among internal malignancies; for prostate, however, high-grade tumors were only moderately affected (–21.7%). Conclusions Diagnosis of cutaneous malignancies was mostly affected by the lockdown; among internal malignancies, corrective actions were mostly needed for colorectal cancer and invasive bladder cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|